Market Cap (In USD)
1.17 Million
Revenue (In USD)
75.4 Thousand
Net Income (In USD)
-4.91 Million
Avg. Volume
504.28 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.1-6.75
- PE
- -
- EPS
- -
- Beta Value
- 0.396
- ISIN
- US6551872012
- CUSIP
- 655187102
- CIK
- 1635077
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Mr. Brent Ness
- Employee Count
- -
- Website
- https://www.aclarion.com
- Ipo Date
- 2022-04-22
- Details
- Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
More Stocks
-
KEIL
-
PNRPantoro Limited
PNR
-
ACARIXAcarix AB (publ)
ACARIX
-
GICSABGrupo Gicsa S.A.B. de C.V.
GICSAB
-
SUKHJITS
-
MCFT
-
BSX
-
ENZYEnzymatica AB (publ)
ENZY